SUBSCRIBE
SUBSCRIBE

Asia

Evidence Supports Use Of “Retainer” Contact Lenses For Nearsightedness In Children, Shangdong University Of Traditional Chinese Medicine Study
February 25, 2015
 · 
5 min read
Together, Nanotechnology And Genetic Interference May Tackle “Untreatable” Brain Tumors, Tel Aviv University Study
February 25, 2015
 · 
3 min read
Job Trends
Takeda Consolidates Singapore Biz; Will Up Headcount by 50% in New Space
February 25, 2015
 · 
2 min read
The Coming Crash In Biotech Stocks
Biotech Bay
BioPharm Executive: Nine Ways to Avoid Investing in Biotech Duds
February 24, 2015
 · 
5 min read
Device Could Help Solve Third World Cervical-Cancer Woes, Biop Medical Reveals
February 24, 2015
 · 
1 min read
Keep Calm, Anger Can Trigger A Heart Attack! University of Sydney Study
February 24, 2015
 · 
3 min read
Analysts Not Sold On Medivation’s Xtandi as Breast Cancer Drug
Biotech Bay
EXCLUSIVE: Evercore ISI Breaks Down Valeant / Salix Deal By the Numbers
February 23, 2015
 · 
1 min read
Sanofi Rumored to Announce Job Cuts in U.S. Before Feb. 9
Biotech Bay
BioSpace Poll Correctly Predicted New Sanofi CEO, Even Naming Correct Candidate
February 23, 2015
 · 
2 min read
Dogs Can Tell If You’re Untrustworthy, Kyoto University Study
February 23, 2015
 · 
1 min read
Fever Alarm Armband: A Wearable, Printable, Temperature Sensor, University of Tokyo Study
February 23, 2015
 · 
2 min read
Load More
PRESS RELEASES
Press Releases
Samsung Epis Holdings Reports Fourth Quarter and Fiscal Year 2025 Financial Results
January 26, 2026
 · 
6 min read
Press Releases
HanchorBio and WuXi Biologics Enter Strategic Partnership to Advance Next-Generation Bi-and Multi-Functional Fusion Protein Pipeline
January 26, 2026
 · 
5 min read
Press Releases
Ascletis Announces First Participants Dosed in a 13-week U.S. Phase II Study with ASC30, an Oral Small Molecule GLP-1R Agonist for the Treatment of Diabetes
January 26, 2026
 · 
4 min read
Press Releases
FDA Accepts LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease under Priority Review
January 26, 2026
 · 
20 min read
Press Releases
Samsung Bioepis Releases First Quarter 2026 US Biosimilar Market Report, Providing Updates to Evolving Drug Pricing Models
January 26, 2026
 · 
2 min read
Press Releases
Adagene Provides Business Update and 2026 Objectives
January 26, 2026
 · 
5 min read
Press Releases
Ellipses In-Licenses First-in-Class B7H3 Antibody Drug Conjugate From China
January 23, 2026
 · 
2 min read
Press Releases
Mabwell Announces First-Patient Dosed in Clinical Trial of Novel CDH17-Targeting ADC 7MW4911 in the U.S.
January 23, 2026
 · 
4 min read
Press Releases
SK bioscience, MSD, and Hilleman Laboratories Advance Zaire ebolavirus Vaccine Development with CEPI Funding
January 23, 2026
 · 
4 min read
Press Releases
SINOVAC Announces Nasdaq Hearings Panel Grants Continued Listing
January 22, 2026
 · 
3 min read
Press Releases
Daiichi Sankyo Appoints New Leadership at the Daiichi Sankyo Translational Research Center Europe
January 22, 2026
 · 
3 min read
Press Releases
AB Science receives Japanese patent protection for the use of masitinib in progressive forms of multiple sclerosis (MS) until 2041
January 22, 2026
 · 
10 min read
Press Releases
Hoth Therapeutics Secures Major International Patent Milestone for HT-KIT Cancer Program, Strengthening Global Oncology IP Position
January 21, 2026
 · 
5 min read
Press Releases
ProImmune Introduces Mastering Immunity 2026 - Shanghai Symposium to Address Key Immunogenicity Challenges
January 21, 2026
 · 
2 min read
Press Releases
Samsung Biologics reports fourth quarter and fiscal year 2025 financial results
January 21, 2026
 · 
5 min read
Press Releases
HistoIndex Partners with Houston Research Institute to Expand Advanced MASH Diagnostic Services
January 21, 2026
 · 
3 min read
Press Releases
Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035
January 21, 2026
 · 
4 min read
Press Releases
Dyne Therapeutics Receives Orphan Drug Designation in Japan for Zeleciment Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1
January 20, 2026
 · 
7 min read
Press Releases
LakeShore Biopharma to Hold Extraordinary General Meeting of Shareholders
January 20, 2026
 · 
6 min read
Press Releases
Ascletis Selects a Next-Generation Once-Monthly Subcutaneously Administered GLP-1R/GIPR/GCGR Triple Peptide Agonist, ASC37, for Clinical Development
January 20, 2026
 · 
4 min read
Load More